A recent trend in psychotherapy research is to add the effects of a psychedelic medication to a therapy session. The renewed interest in these medications ( psilocybin, LSD and MDMA) is due to a number of factors: the cost and length of time psychotherapy alone can take, especially when dealing with issues such as substance addictions, end of life anxiety, post traumatic stress, isolation and depression; the high failure rate of some therapies to effect certain conditions; and the high safety rate of these medications compared to other psychiatric medications. The combination of a long therapy...